Nasdaq · CIK 0002062583
MMED MiniMed Group, Inc.
Insider trading from SEC Form 4. Last filing 8 d ago.
MiniMed Group, Inc. (MMED) has 18 SEC Form 4 filings on file from 11 insiders, the latest filed on Oct 5, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at MiniMed Group, Inc., scored.
Transactions
Every row filed, 47 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Sheila A. Denton SVP, Gen. Counsel & Corp. Sec. | AGrant or award Common Stock | +58,939 | $0.00 | $0 | 58,939 | 8 d ago |
| Mar 25, 2026 | Que Dallara Chief Executive Officer | FTax withholding Common Stock | -4,809 | $16.31 | $78k | 616,754 | Mar 27, 2026 |
| Mar 11, 2026 | Gillian Chandrasena See Remarks | AGrant or award Common Stock | +19,852 | - | - | 19,852 | Mar 13, 2026 |
| Mar 11, 2026 | Courtney Nelson Wills See Remarks | AGrant or award Common Stock | +18,082 | - | - | 18,082 | Mar 13, 2026 |
| Mar 11, 2026 | Chad Spooner EVP, Chief Financial Officer | AGrant or award Common Stock | +70,896 | - | - | 70,896 | Mar 13, 2026 |
| Mar 11, 2026 | Que Dallara Chief Executive Officer | AGrant or award Common Stock | +281,937 | - | - | 281,937 | Mar 13, 2026 |
| Mar 11, 2026 | John Gyurci See Remarks | AGrant or award Common Stock | +15,322 | - | - | 15,322 | Mar 13, 2026 |
| Mar 11, 2026 | Ali Dianaty See Remarks | AGrant or award Common Stock | +11,054 | - | - | 11,054 | Mar 13, 2026 |
| Mar 11, 2026 | Chad Spooner EVP, Chief Financial Officer | AGrant or award Common Stock | +127,609 | - | - | 127,609 | Mar 13, 2026 |
| Mar 11, 2026 | Courtney Nelson Wills See Remarks | AGrant or award Common Stock | +955 | - | - | 955 | Mar 13, 2026 |
| Mar 11, 2026 | Ali Dianaty See Remarks | AGrant or award Common Stock | +46,989 | - | - | 46,989 | Mar 13, 2026 |
| Mar 11, 2026 | Gillian Chandrasena See Remarks | AGrant or award Common Stock | +28,116 | - | - | 28,116 | Mar 13, 2026 |
| Mar 11, 2026 | Que Dallara Chief Executive Officer | AGrant or award Common Stock | +127,609 | - | - | 127,609 | Mar 13, 2026 |
| Mar 11, 2026 | Courtney Nelson Wills See Remarks | AGrant or award Common Stock | +11,486 | - | - | 11,486 | Mar 13, 2026 |
| Mar 11, 2026 | Que Dallara Chief Executive Officer | AGrant or award Common Stock | +57,239 | - | - | 57,239 | Mar 13, 2026 |
| Mar 11, 2026 | Ali Dianaty See Remarks | AGrant or award Common Stock | +35,448 | - | - | 35,448 | Mar 13, 2026 |
| Mar 11, 2026 | Gillian Chandrasena See Remarks | AGrant or award Common Stock | +58,825 | - | - | 58,825 | Mar 13, 2026 |
| Mar 11, 2026 | Chad Spooner EVP, Chief Financial Officer | AGrant or award Common Stock | +70,896 | - | - | 70,896 | Mar 13, 2026 |
| Mar 11, 2026 | Que Dallara Chief Executive Officer | AGrant or award Common Stock | +80,842 | - | - | 80,842 | Mar 13, 2026 |
| Mar 11, 2026 | Ali Dianaty See Remarks | AGrant or award Common Stock | +14,628 | - | - | 14,628 | Mar 13, 2026 |
| Mar 11, 2026 | Courtney Nelson Wills See Remarks | AGrant or award Common Stock | +5,151 | - | - | 5,151 | Mar 13, 2026 |
| Mar 11, 2026 | Gillian Chandrasena See Remarks | AGrant or award Common Stock | +11,486 | - | - | 11,486 | Mar 13, 2026 |
| Mar 11, 2026 | Courtney Nelson Wills See Remarks | AGrant or award Common Stock | +13,646 | - | - | 13,646 | Mar 13, 2026 |
| Mar 11, 2026 | Gillian Chandrasena See Remarks | AGrant or award Common Stock | +11,486 | - | - | 11,486 | Mar 13, 2026 |
| Mar 11, 2026 | Ali Dianaty See Remarks | AGrant or award Common Stock | +33,684 | - | - | 33,684 | Mar 13, 2026 |
| Mar 11, 2026 | Que Dallara Chief Executive Officer | AGrant or award Common Stock | +51,044 | - | - | 51,044 | Mar 13, 2026 |
| Mar 11, 2026 | Que Dallara Chief Executive Officer | AGrant or award Common Stock | +22,892 | - | - | 22,892 | Mar 13, 2026 |
| Mar 11, 2026 | Courtney Nelson Wills See Remarks | AGrant or award Common Stock | +5,743 | - | - | 5,743 | Mar 13, 2026 |
| Mar 11, 2026 | Ali Dianaty See Remarks | AGrant or award Common Stock | +35,448 | - | - | 35,448 | Mar 13, 2026 |
| Mar 11, 2026 | Ali Dianaty See Remarks | AGrant or award Common Stock | +11,563 | - | - | 11,563 | Mar 13, 2026 |
| Mar 11, 2026 | Ali Dianaty See Remarks | AGrant or award Common Stock | +2,444 | - | - | 2,444 | Mar 13, 2026 |
| Mar 9, 2026 | Timothy A Wicks director | AGrant or award Common Stock | +13,889 | $0.00 | $0 | 13,889 | Mar 11, 2026 |
| Mar 9, 2026 | Courtney Nelson Wills See Remarks | AGrant or award Performance-Based Restricted Stock Unitsderivative | +6,945 | $0.00 | $0 | 6,945 | Mar 11, 2026 |
| Mar 9, 2026 | Chad Spooner EVP, Chief Financial Officer | AGrant or award Performance-Based Restricted Stock Unitsderivative | +27,778 | $0.00 | $0 | 27,778 | Mar 11, 2026 |
| Mar 9, 2026 | Kevin E Lofton director | AGrant or award Common Stock | +27,778 | $0.00 | $0 | 27,778 | Mar 11, 2026 |
| Mar 9, 2026 | John Gyurci See Remarks | AGrant or award Performance-Based Restricted Stock Unitsderivative | +2,778 | $0.00 | $0 | 2,778 | Mar 11, 2026 |
| Mar 9, 2026 | D Keith Grossman director | AGrant or award Common Stock | +13,889 | $0.00 | $0 | 13,889 | Mar 11, 2026 |
| Mar 9, 2026 | Glenn A Eisenberg director | AGrant or award Common Stock | +13,889 | $0.00 | $0 | 13,889 | Mar 11, 2026 |
| Mar 9, 2026 | Ali Dianaty See Remarks | AGrant or award Performance-Based Restricted Stock Unitsderivative | +13,889 | $0.00 | $0 | 13,889 | Mar 11, 2026 |
| Mar 9, 2026 | Que Dallara Chief Executive Officer | AGrant or award Performance-Based Restricted Stock Unitsderivative | +83,334 | $0.00 | $0 | 83,334 | Mar 11, 2026 |
| Mar 9, 2026 | Gillian Chandrasena See Remarks | AGrant or award Performance-Based Restricted Stock Unitsderivative | +6,945 | $0.00 | $0 | 6,945 | Mar 11, 2026 |
| Mar 9, 2026 | Ali Dianaty See Remarks | AGrant or award Employee Stock Option (Right to Buy)derivative | +126,263 | $0.00 | $0 | 126,263 | Mar 11, 2026 |
| Mar 9, 2026 | John Gyurci See Remarks | AGrant or award Employee Stock Option (Right to Buy)derivative | +25,253 | $0.00 | $0 | 25,253 | Mar 11, 2026 |
| Mar 9, 2026 | Que Dallara Chief Executive Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +252,526 | $0.00 | $0 | 252,526 | Mar 11, 2026 |
| Mar 9, 2026 | Chad Spooner EVP, Chief Financial Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +84,176 | $0.00 | $0 | 84,176 | Mar 11, 2026 |
| Mar 9, 2026 | Gillian Chandrasena See Remarks | AGrant or award Employee Stock Option (Right to Buy)derivative | +63,132 | $0.00 | $0 | 63,132 | Mar 11, 2026 |
| Mar 9, 2026 | Courtney Nelson Wills See Remarks | AGrant or award Employee Stock Option (Right to Buy)derivative | +63,132 | $0.00 | $0 | 63,132 | Mar 11, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Gillian ChandrasenaSee Remarks
- Que DallaraChief Executive Officer
- Sheila A. DentonSVP, Gen. Counsel & Corp. Sec.
- Ali DianatySee Remarks
- Glenn A Eisenbergofficer, director
- D Keith Grossmandirector
- John GyurciSee Remarks
- Kevin E Loftondirector
- Chad SpoonerEVP, Chief Financial Officer
- Timothy A Wicksdirector
- Courtney Nelson WillsSee Remarks
Questions about MMED
Answered from the filings on this page, as of the latest one.
Are insiders buying MMED?
No. In the last 90 days no insider at MiniMed Group, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade MMED on the open market?
No open-market trade has been scored at MiniMed Group, Inc.. The latest Form 4 on file was filed on Oct 5, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at MiniMed Group, Inc.?
11 people have filed a Form 4 at MiniMed Group, Inc., among them Gillian Chandrasena (See Remarks), Que Dallara (Chief Executive Officer), Sheila A. Denton (SVP, Gen. Counsel & Corp. Sec.). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.